IHE participated in the virtual ISPOR conference with two posters. One in the area of health economic modelling and type-2 diabetes and diabetic nephropathy: Estimated Renal and Cardiovascular Outcomes and Cost Offsets in Patients With Type 2 Diabetes and Diabetic Nephropathy Treated With Canagliflozin.
The second poster presented results from a study utilizing real-world data to examine differences in work absence between patients with newer and older hepatitis C treatments regimens: Societal Productivity Gains From New Therapies in Hepatitis C.